Non transfusional haemochromatosis in patient of thalassemia minor

References

1. Fleming RE, Britton RS, Waheed A, Sly WS, Bacon BR. Pathophysiology of hereditary hemochromatosis. Semin Liver Dis. 2005;25(4):411-9
2. Porter JL, Rawla P. Hemochromatosis. [Updated 2024 Oct 06]. In: Treasure Island (FL): StatPearls Publishing. 2023
3. Rotaru I, Gaman A, Gaman G. Secondary Haemochromatosis in a Patient with Thalassemia Intermedia. Curr Health Sci J. 2014;40(1):67-70.
4. Anderson GJ. Mechanisms of iron loading and toxicity. Am J Hematol. 2007;82(12):1128–31.
5. Sanctis VD, Tangerini A, Testa MR, Lauriola AL, Gamberini MR, Cavallini AR, et al. Final height and endocrine function in thalassaemia intermedia. J Pediatr Endocrinol Metab. 1998;11(Suppl 3):965–971
6. Tanno T, Bhanu NV, Oneal PA, Goh SH, Staker P, Lee YT, et al. High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin. Nat Med. 2007;13(9):1096–101.
7. Dhillon BK, Das R, Garewal G, Chawla Y, Dhiman RK, Das A, et al. Frequency of primary iron overload and HFE gene mutations (C282Y, H63D and S65C) in chronic liver disease patients in north India. World J Gastroenterol. 2007;13(21):2956–9.
8. Jain S, Agarwal S, Tamhankar P, Verma P, Choudhuri G. Lack of association of primary iron overload and common HFE gene mutations with liver cirrhosis in adult Indian population. Indian J Gastroenterol. 2011;30(4):161–5.
9. Dhillon BK, Chopra G, Jamwal M, Chandak GR, Duseja A, Malhotra P, et al. Adult onset hereditary hemochromatosis is associated with a novel recurrent Hemojuvelin (HJV) gene mutation in north Indians. Blood Cells Mol Dis. 2018;73:14–21.